HEPATOCELLULAR CARCINOMA RECURRENT
Clinical trials for HEPATOCELLULAR CARCINOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA RECURRENT trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver transplant patients with recurrent cancer: safety trial launched
Disease control Recruiting nowThis study tests whether a combination of two drugs, atezolizumab and bevacizumab, is safe for liver transplant patients whose liver cancer has returned and cannot be treated with surgery or local therapies. About 50 participants will receive the drug combination along with a sta…
Matched conditions: HEPATOCELLULAR CARCINOMA RECURRENT
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 11:59 UTC
-
New device offers hope for advanced liver cancer patients with no other options
Disease control Recruiting nowThis study is for people with advanced liver cancer that has not responded to at least two prior treatments. It tests a device called TheraBionic P1, which is used at home to see if it can help people live longer and improve their quality of life. About 198 participants will be f…
Matched conditions: HEPATOCELLULAR CARCINOMA RECURRENT
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated May 14, 2026 12:04 UTC